20
Fresenius Kabi Oncology Limited Kalyani In, based in India, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
One of their significant offerings is Paclitaxel, Semi-synthetic process, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2008-181 - Rev 10
This Chemical Type CEP, issued on October 17, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1794 associated with this CEP further emphasizes